J&J COVID-19 Vaccine 66 Percent Effective in Interim Analysis
Efficacy varies by region, with 57 percent efficacy in South Africa and 72 percent efficacy in the United States
COVID-19 Admissions, Fatalities Up for Pregnant Women
COVID-19 hospitalization rates 3.5-fold higher, case fatality rates 13.6-fold higher in pregnant patients versus similarly aged adults
Schizophrenia Linked to Mortality in Adults With COVID-19
In terms of strength of association with mortality, diagnosis of schizophrenia ranked only behind age
Physician’s Briefing Weekly Coronavirus Roundup
New COVID-19 Variants May Weaken Efficacy of Vaccines
But experts stress that even a weakened vaccine can still largely protect people from a severe case of COVID-19
SARS-CoV-2 Seroconversion Tied to Out-of-Hospital Sudden Deaths
Moderate positive correlation seen between OHSD and percentage of positive antibody tests to SARS-CoV-2 in NYC neighborhoods
EU Regulator Approves Oxford-AstraZeneca COVID-19 Vaccine
Vaccine is added to those made by Pfizer and Moderna, which have already been approved in the EU
Nearly Half of U.S. Adults Want the COVID-19 Vaccine as Soon as Possible
Messages about effectiveness of the vaccine and the experience of friends and family are most influential factors
Guidance Issued for COVID-19 Vaccination of Cancer Patients
Patients with cancer should be prioritized for vaccination; caregivers and household/close contacts should undergo vaccination when possible
Early Anticoagulation May Not Up Survival in Severe COVID-19
Venous thromboembolism seen in 6.3 percent and major bleeding seen in 2.8 percent of critically ill COVID-19 patients
